National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation.

ABSTRACT:

Background

Cervical cancer is the leading cause of cancer among women in Tanzania, with approximately 10,000 new cases and 7,000 deaths annually. In April 2018, the Government of Tanzania introduced 2 doses of human papillomavirus (HPV) vaccine nationally to adolescent girls to prevent cervical cancer, following a successful 2-year pilot introduction of the vaccine in the Kilimanjaro Region.

Methods

We interviewed key informants at the national level in Tanzania from February to November 2019, using a semi-structured tool to better understand national decision-making and program implementation. We conducted a comprehensive desk review of HPV vaccine introduction materials and reviewed administrative coverage data.

Results

Ten key informants were interviewed from the M

SUBMITTER: Mphuru A 

PROVIDER: S-EPMC9601814 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature